Tag Archives: Laguna Niguel

Suspended Connecticut priest admits to meth charge, faces up to 14 years

A suspended Roman Catholic priest accused of making more than $300,000 in methamphetamine sales out of his Connecticut apartment and running an adult video and sex toy shop pleaded guilty Tuesday to a federal drug charge.

Kevin Wallin, of Waterbury, admitted to conspiracy to possess with intent to distribute methamphetamine and was scheduled to be sentenced June 25. The agreed-upon sentence is 11 to 14 years.

Prosecutors said the 61-year-old Wallin had meth mailed to him from co-conspirators in California and sold the drugs out of his Waterbury apartment last year. He sold nearly four pounds in all, prosecutors said. He also bought an adult video and sex toy shop in North Haven named Land of Oz & Dorothy’s Place, apparently to launder the drug money, authorities said.

Dubbed in some media as “Monsignor Meth,” Wallin was pastor of St. Augustine Parish in Bridgeport for nine years until he resigned in June 2011, citing health and personal reasons. He previously served six years as pastor of St. Peter’s Church in Danbury until 2002.

He was granted a sabbatical in July 2011. The Diocese of Bridgeport suspended him from public ministry last May.

He was arrested in January, and a grand jury indicted him and four other people on drug charges.

An undercover officer bought meth from Wallin six times from Sept. 20 to Jan. 2, paying more than $3,400 in total for 23 grams of the drug, authorities said.

Federal agents said they learned through wiretaps and informants about other sales Wallin was making.

Connecticut U.S. Attorney David Fein has said the arrests dismantled “a significant methamphetamine distribution organization that spanned from California to Connecticut.”

On social media, people couldn’t help but compare Wallin with Walter White, the main character on “Breaking Bad,” who was making so much cash that he and his wife bought a car wash to launder their profits.

Also charged in the case were Kenneth Devries of Waterbury; Michael Nelson of Manchester; Chad McCluskey of San Clemente, Calif.; and Kristen Laschober of Laguna Niguel, Calif. Authorities say McCluskey and Laschober were involved in the shipping of methamphetamine to Wallin.

…read more
Source: FULL ARTICLE at Fox US News

Tight Housing Inventory Is Really Starting to Pinch

By Karl Smith, Contributor

From NAR Economist Lawrence Yun “The volume of home sales appears to be leveling off with the constrained inventory conditions” Sadly, we’ve seen this story before. Someone is going to get their heart broken. Still, hope springs. The second act is, as always, the best. From the LA Times: Here’s some good news on the mortgage availability front as you house-hunt this weekend: Credit standards appear to be easing, just a bit, according to an analytical study and reports from front-line lenders. . . . Cohen said he’s also seen a slight loosening of borrower worthiness gauges such as the debt-to-income ratio. “There’s a slight credit easing, but in a subtle way,” he said. For people with less than 20% down payments, mortgage insurance is now easier to get, said Jeff Lazerson,  a Laguna Niguel mortgage broker. I can’t wait to see how it all ends. Truly. This is gonna be interesting. …read more
Source: FULL ARTICLE at Forbes Latest

Barfresh Announces Shipment of Product and Initial Locations for Major Chain's Smoothie Test Markets

By Business Wirevia The Motley Fool

Filed under:

Barfresh Announces Shipment of Product and Initial Locations for Major Chain’s Smoothie Test Markets

DENVER–(BUSINESS WIRE)– Barfresh Food Group, Inc. (OTC:BRFH) (“Barfresh Food Group,” “Barfresh” or the “Company”), a manufacturer and distributor of unique ready to blend beverages, today announced that flavors have been approved and test markets have been selected by the premiere Quick Service Restaurant (QSR) chain announced by the Company in November 2012. Initial shipments of Barfresh pre-portioned ready to blend ingredient packs will commence this spring. The announcement was made by the Company at the 25th Annual Roth Conference being held in Laguna Niguel, California.

The chain, which consists of approximately 3,000 franchise locations, has selected San Diego, California; Houston, Texas; and a selected market in Canada as initial markets for the product.

Barfresh CEO Riccardo Delle Coste said, “We are very excited about the rollout into these markets. Large QSR chains are right in the sweet spot for our business model and operations. Once the product has been shipped to these markets, we anticipate that we can identify this customer.”

About Barfresh Food Group, Inc.

Barfresh Food Group, Inc. is a manufacturer and distributor of ready to blend beverages. The Company utilizes a proprietary patent pending system, using controlled pre-packaged portions, to deliver a freshly made smoothie that’s quick, cost efficient and with no waste. Barfresh Food Group, Inc. utilizes contract manufacturing facilities to complete the manufacturing of its sealed pack of ingredients for an individual smoothie.

The Company sells ready to blend all natural beverages primarily to restaurant chains in the QSR and casual dining sectors. In the future it intends to target other segments of the food service industry as well as the retail consumer market, including grocery stores and other retail outlets.

Forward-Looking Statement Notice:

This press release includes “forward-looking statements” as defined by the U.S. Securities and Exchange Commission (the “SEC”). All statements, other than statements of historical fact, included in the press release that address activities, events or developments that the Company believes or anticipates will or may occur in the future are forward-looking statements. These statements are based on certain assumptions made based on experience, expected future developments and other factors the Company believes are appropriate under the circumstances. Such statements are subject to a …read more
Source: FULL ARTICLE at DailyFinance

PowerSecure to Present at the 25th Annual ROTH Conference

By Business Wirevia The Motley Fool

Filed under:

PowerSecure to Present at the 25 th Annual ROTH Conference

WAKE FOREST, N.C.–(BUSINESS WIRE)– PowerSecure International, Inc. (NAS: POWR) will present at the 25th Annual ROTH Conference at the Ritz-Carlton, Laguna Niguel, CA at 11:30 a.m. PT/2:30 p.m. ET on Wednesday, March 20, 2013.

A link to an audio webcast of the event will be available on the Investor Relations section of the company’s web site at www.powersecure.com.

About PowerSecure

PowerSecure International, Inc. is a leading provider of utility and energy technologies to electric utilities, and their industrial, institutional and commercial customers. PowerSecure provides products and services in the areas of Interactive Distributed Generation® (IDG®), energy efficiency and utility infrastructure. The company is a pioneer in developing IDG® power systems with sophisticated smart grid capabilities, including the ability to 1) forecast electricity demand and electronically deploy the systems to deliver more efficient, and environmentally friendly, power at peak power times, 2) provide utilities with dedicated electric power generation capacity to utilize for demand response purposes and 3) provide customers with the most dependable standby power in the industry. Its proprietary distributed generation system designs utilize a range of technologies to deliver power, including renewables. The company’s energy efficiency business develops energy efficient lighting technologies that improve the quality of light, including its proprietary EfficientLights® LED lighting products for grocery, drug and convenience stores, and its SecureLite area light and PowerLite street lights for utilities and municipalities. PowerSecure also provides electric utilities with transmission and distribution infrastructure maintenance and construction services, and engineering and regulatory consulting services. Additional information is available at www.powersecure.com.

PowerSecure International, Inc.
John Bluth, +1 919-453-2103

KEYWORDS:   United States  North America  North Carolina

INDUSTRY KEYWORDS:

The article PowerSecure to Present at the 25th Annual ROTH Conference originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

…read more
Source: FULL ARTICLE at DailyFinance

Spectrum Pharmaceuticals to Present Corporate Update at the 25th Annual ROTH Conference in Laguna Ni

By Business Wirevia The Motley Fool

Filed under:

Spectrum Pharmaceuticals to Present Corporate Update at the 25th Annual ROTH Conference in Laguna Niguel on March 20th

HENDERSON, Nev.–(BUSINESS WIRE)– Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that an overview of the Company’s business strategy and commercial and development-stage programs will be given at the 25th Annual ROTH Conference being held at The Ritz-Carlton Hotel in Laguna Niguel, California. The Company presentation is on Wednesday, March 20, 2013, at 11:00 AM PT.

A live webcast of Spectrum’s presentation will be available at http://www.sppirx.com.

About Spectrum Pharmaceuticals, Inc.

Spectrum Pharmaceuticals is a leading biotechnology company focused on acquiring, developing, and commercializing drug products, with a primary focus in oncology and hematology. Spectrum and its affiliates market three oncology drugs ─ FUSILEV® (levoleucovorin) for Injection in the U.S.; FOLOTYN® (pralatrexate injection), also marketed in the U.S.; and ZEVALIN® (ibritumomab tiuxetan) Injection for intravenous use, for which the Company has worldwide marketing rights. Spectrum’s strong track record in in-licensing and acquiring differentiated drugs, and expertise in clinical development have generated a robust, diversified, and growing pipeline of product candidates in advanced-stage Phase 2 and Phase 3 studies. More information on Spectrum is available at www.sppirx.com.

Forward-looking statement — This press release may contain forward-looking statements regarding future events and the future performance of Spectrum Pharmaceuticals that involve risks and uncertainties that could cause actual results to differ materially. These statements are based on management’s current beliefs and expectations. These statements include, but are not limited to, statements that relate to our business and its future, including certain company milestones, Spectrum’s ability to identify, acquire, develop and commercialize a broad and diverse pipeline of late-stage clinical and commercial products, leveraging the expertise of partners and employees around the world to assist us in the execution of our strategy, and any statements that relate to the intent, belief, plans or expectations of Spectrum or its management, or that are not a statement of historical fact. Risks that could cause actual results to differ include the possibility that our existing and new drug candidates may not prove safe or effective, the possibility that our existing and new applications to the FDA and other regulatory agencies may not receive approval in a timely manner or at all, the possibility that our existing and new drug candidates, if approved, may not be …read more
Source: FULL ARTICLE at DailyFinance

TriMas Corporation to Present at Roth Annual Growth Stock Conference and Sidoti Annual Emerging Grow

By Business Wirevia The Motley Fool

Filed under:

TriMas Corporation to Present at Roth Annual Growth Stock Conference and Sidoti Annual Emerging Growth Institutional Investor Forum

BLOOMFIELD HILLS, Mich.–(BUSINESS WIRE)– TriMas Corporation (NAS: TRS) – a diversified global manufacturer of engineered and applied products – today announced that TriMas management is scheduled to present at the Roth 25th Annual OC Growth Stock Conference on Monday, March 18, 2012 at 11:30 a.m. PDT in Laguna Niguel, California. The live webcast will be available in the Investor Relations section of the Company’s website at www.trimascorp.com or at http://wsw.com/webcast/roth27/trs/.

The Company is also presenting at the Sidoti 17th Annual Emerging Growth Institutional Investor Forum on Tuesday, March 19 in New York City.


About TriMas

Headquartered in Bloomfield Hills, Michigan, TriMas Corporation (NAS: TRS) provides engineered and applied products for growing markets worldwide.TriMas is organized into six reportable segments: Packaging, Energy, Aerospace & Defense, Engineered Components, Cequent Asia Pacific and Cequent Americas. TriMas has approximately 5,500 employees at more than 60 different facilities in 17 countries. For more information, visit www.trimascorp.com.

TriMas Corporation
Christine Parker
Communications Specialist
(248) 631-5438
christineparker@trimascorp.com

KEYWORDS:   United States  North America  California  Michigan  New York

INDUSTRY KEYWORDS:

The article TriMas Corporation to Present at Roth Annual Growth Stock Conference and Sidoti Annual Emerging Growth Institutional Investor Forum originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

(function(c,a){window.mixpanel=a;var b,d,h,e;b=c.createElement(“script”);
b.type=”text/javascript”;b.async=!0;b.src=(“https:”===c.location.protocol?”https:”:”http:”)+
‘//cdn.mxpnl.com/libs/mixpanel-2.2.min.js’;d=c.getElementsByTagName(“script”)[0];
d.parentNode.insertBefore(b,d);a._i=[];a.init=function(b,c,f){function d(a,b){
var c=b.split(“.”);2==c.length&&(a=a[c[0]],b=c[1]);a[b]=function(){a.push([b].concat(
Array.prototype.slice.call(arguments,0)))}}var g=a;”undefined”!==typeof f?g=a[f]=[]:
f=”mixpanel”;g.people=g.people||[];h=[‘disable’,’track’,’track_pageview’,’track_links’,
‘track_forms’,’register’,’register_once’,’unregister’,’identify’,’alias’,’name_tag’,
‘set_config’,’people.set’,’people.increment’];for(e=0;e<h.length;e++)d(g,h[e]);
a._i.push([b,c,f])};a.__SV=1.2;})(document,window.mixpanel||[]);
mixpanel.init("9659875b92ba8fa639ba476aedbb73b9");
…read more
Source: FULL ARTICLE at DailyFinance

TESSCO to Present at 25th Annual Roth Conference on March 19, 2013

By Business Wirevia The Motley Fool

Filed under:

TESSCO to Present at 25 th Annual Roth Conference on March 19, 2013


Provides Fourth Quarter Revenue Estimates and Updates Annual Guidance

HUNT VALLEY, Md.–(BUSINESS WIRE)– TESSCO Technologies Incorporated (NAS: TESS) , a leading provider of the product and value chain solutions required to build, use and maintain wireless broadband systems, today announced that it will present at the 25th Annual Roth Conference. The Company also provided an update on its business outlook for its fiscal 2013 fourth quarter and the fiscal year.

Presentation at Roth Conference

The 25th Annual Roth Conference will be held at the Ritz-Carlton in Laguna Niguel, CA. TESSCO will present at 4:30 PM PT in Salon 2 – Blue. The company will also meet one-on-one with institutional investors during the day. To obtain additional information about TESSCO‘s participation in the conference, please contact TESSCO‘s investor relations representative, LHA.

Business Outlook

TESSCO expects to report revenue in the range of $148 million to $160 million for the fourth fiscal quarter, which ends March 30, 2013. This fourth quarter revenue as compared to the prior year fourth quarter would reflect approximately a 5-12% increase in our core markets and an 18-24% decrease in total revenue as a result of the ongoing transition out of the third party logistics business with a Tier 1 carrier. As previously announced, we expect to be completely transitioned out of this 3PL relationship by the end of our fiscal year.

Based on the results in the first three quarters of fiscal 2013 and expected results for the fourth quarter, diluted earnings per share for fiscal 2013 are expected to be in the range of $2.09 to $2.15. This is an update from the previous range of $2.05 to $2.15.

Final results for fiscal 2013, as well as an outlook for fiscal year 2014 will be announced on May 8, 2013.

About TESSCO

<a target=_blank …read more
Source: FULL ARTICLE at DailyFinance

ACADIA Pharmaceuticals to Present at the 25th Annual ROTH Conference on March 19, 2013

By Business Wirevia The Motley Fool

Filed under:

ACADIA Pharmaceuticals to Present at the 25 th Annual ROTH Conference on March 19, 2013

SAN DIEGO–(BUSINESS WIRE)– ACADIA Pharmaceuticals Inc. (NAS: ACAD) , a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will present at the 25th Annual ROTH Conference on Tuesday, March 19, 2013, at 10:00 a.m. Pacific Time at The Ritz-Carlton in Laguna Niguel.

A live webcast of ACADIA‘s presentation will be accessible on the company’s website, www.acadia-pharm.com, under the investors section and an archived recording will be available on the website through April 2, 2013.

About ACADIA Pharmaceuticals

ACADIA is a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders. ACADIA has a pipeline of product candidates led by pimavanserin, which is in Phase III development as a potential first-in-class treatment for Parkinson’s disease psychosis. ACADIA also has clinical-stage programs for chronic pain and glaucoma in collaboration with Allergan, Inc. and two advanced preclinical programs directed at Parkinson’s disease and other neurological disorders. All product candidates are small molecules that emanate from discoveries made at ACADIA. ACADIA maintains a website at www.acadia-pharm.com to which ACADIA regularly posts copies of its press releases as well as additional information and through which interested parties can subscribe to receive email alerts.

Forward-Looking Statements

Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements include but are not limited to statements related to the progress and timing of ACADIA‘s drug discovery and development programs, either alone or with a partner, including clinical trials, and the benefits to be derived from ACADIA‘s product candidates, in each case including pimavanserin. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties. Actual events or results may differ materially from those projected in any of such statements due to various factors, including the risks and uncertainties inherent in drug discovery, development and commercialization, and collaborations with others, and the fact that past results of clinical trials may not be indicative of future trial results. For a discussion of these and other factors, please refer to ACADIA‘s annual report on Form 10-K for the year ended December 31, 2012 …read more
Source: FULL ARTICLE at DailyFinance

BioTime to Present at 25th Annual ROTH Conference

By Business Wirevia The Motley Fool

Filed under:

BioTime to Present at 25th Annual ROTH Conference

ALAMEDA, Calif.–(BUSINESS WIRE)– BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Dr. Michael D. West, Chief Executive Officer, will present a corporate overview of BioTime and its subsidiaries at the 25th Annual ROTH Conference. The presentation will take place on Monday, March 18, 2013 at 5:30 p.m. PDT at The Ritz-Carlton, Laguna Niguel, in Dana Point, California. The presentation will be webcast and available online at the “Investors” section of the website at www.biotimeinc.com and at http://wsw.com/webcast/roth27/btx/.


About BioTime, Inc.

BioTime, headquartered in Alameda, California, is a biotechnology company focused on regenerative medicine and blood plasma volume expanders. Its broad platform of stem cell technologies is enhanced through subsidiaries focused on specific fields of application. BioTime develops and markets research products in the fields of stem cells and regenerative medicine, including a wide array of proprietary PureStem™ cell lines, HyStem® hydrogels, culture media, and differentiation kits. BioTime is developing Renevia™ (formerly known as HyStem®Rx), a biocompatible, implantable hyaluronan and collagen-based matrix for cell delivery in human clinical applications. BioTime’s therapeutic product development strategy is pursued through subsidiaries that focus on specific organ systems and related diseases for which there is a high unmet medical need. BioTime’s majority-owned subsidiary Cell Cure Neurosciences Ltd. is developing therapeutic products derived from stem cells for the treatment of retinal and neural degenerative diseases. BioTime’s subsidiary OrthoCyte Corporation is developing therapeutic applications of stem cells to treat orthopedic diseases and injuries. Another subsidiary, OncoCyte Corporation, focuses on the diagnostic and therapeutic applications of stem cell technology in cancer, including the diagnostic product PanC-Dx™ currently being developed for the detection of cancer in blood samples. ReCyte Therapeutics, Inc. is developing applications of BioTime’s proprietary induced pluripotent stem cell technology to reverse the developmental aging of human cells to treat cardiovascular and blood cell diseases. BioTime’s subsidiary LifeMap Sciences, Inc. markets GeneCards®, the leading human gene database, as part of an integrated database suite that also includes the LifeMap Discovery™ database of embryonic development, stem cell research and regenerative medicine, and MalaCards, the human disease database. LifeMap Sciences also markets BioTime research products and PanDaTox, an innovative, recently developed, searchable database that can aid in the discovery of new antibiotics and biotechnologically beneficial products. BioTime Acquisition Corporation is a new subsidiary being used to acquire the stem cell …read more
Source: FULL ARTICLE at DailyFinance

Dendreon Announces Webcast Presentation at ROTH Conference

By Business Wirevia The Motley Fool

Filed under:

Dendreon Announces Webcast Presentation at ROTH Conference

SEATTLE–(BUSINESS WIRE)– March 12, 2013—Dendreon Corporation (NAS: DNDN) today announced that management will present at the 25th Annual ROTH Conference in Laguna Niguel, California, on March 18, 2013, at 11:00 a.m. PT.

The presentation will be webcast live and available for replay from Dendreon’s website, www.dendreon.com. If you are unable to listen to the live webcast, it will be archived on the site following the presentation. To access the replay, go to the Investor Relations section of the website.

About Dendreon

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development, commercialization and manufacturing of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy (ACI) product candidates designed to stimulate an immune response in a variety of tumor types. Dendreon’s first product, PROVENGE® (sipuleucel-T), was approved by the U.S. Food and Drug Administration (FDA) in April 2010. Dendreon is exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. The Company is headquartered in Seattle, Washington, and is traded on the NASDAQ Global Market under the symbol DNDN. For more information about the Company and its programs, visit http://www.dendreon.com/.

Dendreon Corporation
Corporate Communications
Lindsay Rocco, 862-596-1304
media@dendreon.com
or
Dendreon Corporation
Investor Relations
Nicole Soley, 206-455-2384
InvestorRelations@dendreon.com

KEYWORDS:   United States  North America  California  Washington

INDUSTRY KEYWORDS:

The article Dendreon Announces Webcast Presentation at ROTH Conference originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

(function(c,a){window.mixpanel=a;var b,d,h,e;b=c.createElement(“script”);
b.type=”text/javascript”;b.async=!0;b.src=(“https:”===c.location.protocol?”https:”:”http:”)+
‘//cdn.mxpnl.com/libs/mixpanel-2.2.min.js’;d=c.getElementsByTagName(“script”)[0];
d.parentNode.insertBefore(b,d);a._i=[];a.init=function(b,c,f){function d(a,b){
var c=b.split(“.”);2==c.length&&(a=a[c[0]],b=c[1]);a[b]=function(){a.push([b].concat(
Array.prototype.slice.call(arguments,0)))}}var g=a;”undefined”!==typeof f?g=a[f]=[]:
f=”mixpanel”;g.people=g.people||[];h=[‘disable’,’track’,’track_pageview’,’track_links’,
…read more
Source: FULL ARTICLE at DailyFinance

Cognex to Present at 25th Annual Roth Conference

By Business Wirevia The Motley Fool

Filed under:

Cognex to Present at 25 th Annual Roth Conference

NATICK, Mass.–(BUSINESS WIRE)– Cognex Corporation (NAS: CGNX) announced today that Robert J. Shillman, Founder, Chairman and Chief Culture Officer of Cognex, will discuss the company’s performance and future prospects at the 25th Annual Roth Conference at The Ritz-Carlton, Laguna Niguel in Dana Point, California. Dr. Shillman’s presentation will be on Tuesday, March 19, 2013, beginning at 12:00 p.m. eastern time.

Internet users can listen to a real-time audio broadcast of the presentation, or an archived recording, on the Cognex Investor Relations website: http://www.cognex.com/Investor.

About Cognex Corporation

Cognex Corporation designs, develops, manufactures and markets a range of products that incorporate sophisticated machine vision technology that gives them the ability to “see.” Cognex products include barcode readers, machine vision sensors and machine vision systems that are used in factories, warehouses and distribution centers around the world to guide, gauge, inspect, identify and assure the quality of items during the manufacturing and distribution process. Cognex is the world’s leader in the machine vision industry, having shipped more than 850,000 vision-based products, representing over $3 billion in cumulative revenue, since the company’s founding in 1981. Headquartered in Natick, Massachusetts, USA, Cognex has regional offices and distributors located throughout North America, Japan, Europe, Asia and Latin America. For details visit Cognex online at http://www.cognex.com.

Cognex Corporation
Susan Conway, 508-650-3353
Director of Investor Relations
susan.conway@cognex.com

KEYWORDS:   United States  North America  Massachusetts

INDUSTRY KEYWORDS:

The article Cognex to Present at 25th Annual Roth Conference originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

(function(c,a){window.mixpanel=a;var b,d,h,e;b=c.createElement(“script”);
b.type=”text/javascript”;b.async=!0;b.src=(“https:”===c.location.protocol?”https:”:”http:”)+
‘//cdn.mxpnl.com/libs/mixpanel-2.2.min.js’;d=c.getElementsByTagName(“script”)[0];
d.parentNode.insertBefore(b,d);a._i=[];a.init=function(b,c,f){function d(a,b){
var c=b.split(“.”);2==c.length&&(a=a[c[0]],b=c[1]);a[b]=function(){a.push([b].concat(
Array.prototype.slice.call(arguments,0)))}}var g=a;”undefined”!==typeof f?g=a[f]=[]:
f=”mixpanel”;g.people=g.people||[];h=[‘disable’,’track’,’track_pageview’,’track_links’,
‘track_forms’,’register’,’register_once’,’unregister’,’identify’,’alias’,’name_tag’,
‘set_config’,’people.set’,’people.increment’];for(e=0;e<h.length;e++)d(g,h[e]);
a._i.push([b,c,f])};a.__SV=1.2;})(document,window.mixpanel||[]);
mixpanel.init("9659875b92ba8fa639ba476aedbb73b9");

…read more
Source: FULL ARTICLE at DailyFinance

Delta Apparel, Inc. to Present at the 25th Annual ROTH Conference

By Business Wirevia The Motley Fool

Filed under:

Delta Apparel, Inc. to Present at the 25 th Annual ROTH Conference

GREENVILLE, S.C.–(BUSINESS WIRE)– Delta Apparel, Inc. (NYSE MKT: DLA) announced today that the Company will deliver a presentation on its business strategy and financial results to investors at the 25th Annual ROTH Conference being held at the Ritz-Carlton in Laguna Niguel, California. The presentation is scheduled for Monday, March 18, 2013, at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time).

A webcast of the conference presentation will be available on Delta Apparel‘s website at www.deltaapparelinc.com. Real Player or Windows Media Player is required to listen to the webcast.

About Delta Apparel, Inc.

Delta Apparel, Inc., along with its operating subsidiaries, M. J. Soffe, LLC, Junkfood Clothing Company, To The Game, LLC and Art Gun, LLC, is an international design, marketing, manufacturing, and sourcing company that features a diverse portfolio of lifestyle branded activewear apparel and headwear, and produces high quality private label programs. The Company specializes in selling casual and athletic products across distribution tiers and in most store types, including specialty stores, boutiques, department stores, mid-tier and mass chains. From a niche distribution standpoint, the Company also has strong distribution at college bookstores and the U.S. military. The Company’s products are made available direct-to-consumer on its websites at www.soffe.com, www.junkfoodclothing.com, www.saltlife.com and www.deltaapparel.com. Additional products can be viewed at www.2thegame.com and www.thecottonexchange.com. The Company’s operations are located throughout the United States, Honduras, El Salvador, and Mexico, and it employs approximately 7,100 people worldwide. Additional information about the Company is available at www.deltaapparelinc.com.

Delta Apparel, Inc.
Deborah Merrill, 864-232-5200 x6620
Chief Financial Officer
or
Investor Relations
Sally Wallick, 404-806-1398
CFA
investor.relations@deltaapparel.com

KEYWORDS:   United States  North America  South Carolina

INDUSTRY KEYWORDS:

The article Delta Apparel, Inc. to Present at the 25th Annual ROTH Conference originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

…read more
Source: FULL ARTICLE at DailyFinance

ImmunoCellular Therapeutics to Present at ROTH Conference on March 18th

By Business Wirevia The Motley Fool

Filed under:

ImmunoCellular Therapeutics to Present at ROTH Conference on March 18th

LOS ANGELES–(BUSINESS WIRE)– ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (NYSE MKT: IMUC) today announced that Andrew Gengos, Chief Executive Officer of ImmunoCellular, will present a corporate overview and business update at the 25th Annual ROTH Conference on Monday, March 18, 2013 at 1:30 pm PT at the Ritz-Carlton, Laguna Niguel, CA.

To access the live audio webcast of the ROTH presentation, please log on through a link located in the Investors section of ImmunoCellular’s website at www.imuc.com, under the Events & Presentations tab. A replay of the webcast will be available one hour after the conclusion of the live event.

About ImmunoCellular Therapeutics, Ltd.

ImmunoCellular Therapeutics, Ltd. is a Los Angeles-based clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers. ImmunoCellular is conducting a Phase II trial of its lead product candidate, ICT-107, a dendritic cell-based vaccine targeting multiple tumor-associated antigens for glioblastoma. ImmunoCellular’s pipeline also includes ICT-121, a dendritic cell vaccine targeting CD133, and ICT-140, a dendritic cell vaccine targeting ovarian cancer antigens and cancer stem cells. To learn more about ImmunoCellular, please visit www.imuc.com.

For ImmunoCellular Therapeutics, Ltd.
Jane Green
Investor Relations
415.348.0010
jane@jmgcomm.com

KEYWORDS:   United States  North America  California

INDUSTRY KEYWORDS:

The article ImmunoCellular Therapeutics to Present at ROTH Conference on March 18th originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

(function(c,a){window.mixpanel=a;var b,d,h,e;b=c.createElement(“script”);
b.type=”text/javascript”;b.async=!0;b.src=(“https:”===c.location.protocol?”https:”:”http:”)+
‘//cdn.mxpnl.com/libs/mixpanel-2.2.min.js’;d=c.getElementsByTagName(“script”)[0];
d.parentNode.insertBefore(b,d);a._i=[];a.init=function(b,c,f){function d(a,b){
var c=b.split(“.”);2==c.length&&(a=a[c[0]],b=c[1]);a[b]=function(){a.push([b].concat(
Array.prototype.slice.call(arguments,0)))}}var g=a;”undefined”!==typeof f?g=a[f]=[]:
f=”mixpanel”;g.people=g.people||[];h=[‘disable’,’track’,’track_pageview’,’track_links’,
‘track_forms’,’register’,’register_once’,’unregister’,’identify’,’alias’,’name_tag’,
‘set_config’,’people.set’,’people.increment’];for(e=0;e<h.length;e++)d(g,h[e]);
a._i.push([b,c,f])};a.__SV=1.2;})(document,window.mixpanel||[]);
mixpanel.init("9659875b92ba8fa639ba476aedbb73b9");

function addEvent(obj, evType, fn, useCapture){
if (obj.addEventListener){
…read more
Source: FULL ARTICLE at DailyFinance

Natus to Present at Roth 25th Annual OC Growth Stock Conference

By Business Wirevia The Motley Fool

Filed under:

Natus to Present at Roth 25 th Annual OC Growth Stock Conference

– Webcast Available on Company Web Site

SAN CARLOS, Calif.–(BUSINESS WIRE)– Natus Medical Incorporated (NAS: BABY) today announced that the Company is scheduled to present at an upcoming financial conference.

Jim Hawkins, Chief Executive Officer of the Company, will make a presentation at the Roth Capital Partners 25th Annual OC Growth Stock Conference. The conference is being held at the Ritz-Carlton Hotel, Laguna Niguel, California on March 17-20, 2013. Mr. Hawkins is scheduled to present on Monday, March 18 at 9:30 a.m. Pacific Time (12:30 p.m. ET). Attendance at the Roth Capital Partners 25th Annual OC Growth Stock Conference is by invitation only.

Investors may listen to a live webcast via the “Investors” section of the Company’s web site at http://investor.natus.com. Since the presentation will be in a fireside chat format there will be no presentation slides during the webcast. The recorded webcast will be accessible online for at least 30 days.

About Natus Medical

Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn’s environment, and software systems for managing and tracking disorders and diseases for public health laboratories.

Additional information about Natus Medical can be found at www.natus.com.

Natus Medical Incorporated
Steven J. Murphy
Chief Financial Officer
(650) 802-0400
InvestorRelations@Natus.com

KEYWORDS:   United States  North America  California

INDUSTRY KEYWORDS:

The article Natus to Present at Roth 25th Annual OC Growth Stock Conference originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that <a target=_blank …read more
Source: FULL ARTICLE at DailyFinance

Ultratech, Inc. Announces Participation in March Conferences

By Business Wirevia The Motley Fool

Filed under:

Ultratech, Inc. Announces Participation in March Conferences

SAN JOSE, Calif.–(BUSINESS WIRE)– Ultratech, Inc.  (NAS: UTEK) , a leading supplier of lithography and laser-processing systems used to manufacture semiconductor devices and high-brightness LEDs (HB-LEDs), today announced that it will present at the 25th Annual Roth Conference on Monday, March 18, 2013, at 1:00pm PT in Laguna Niguel, CA. To listen to the audio webcast of the presentation during or after the event, please visit http://ir.ultratech.com/. The replay will be available for 30 days after the event.

Ultratech will also participate in Sidoti’s Seventeenth Annual Emerging Growth Institutional Investor Forum in New York on March 18, 2013.

About Ultratech: Ultratech, Inc.  (NAS: UTEK) designs, manufactures and markets photolithography and laser processing equipment. Founded in 1979, the company’s market-leading advanced lithography products deliver high throughput and production yields at a low, overall cost of ownership for bump packaging of integrated circuits and high-brightness LEDs (HB-LEDs). A pioneer of laser processing, Ultratech developed laser spike anneal technology, which increases device yield, improves transistor performance and enables the progression of Moore’s Law for 32-nm and below production of state-of-the-art consumer electronics. Visit Ultratech online at: www.ultratech.com.

(UTEK-F)

Company Contact:
Ultratech, Inc.
Bruce R. Wright, 408-321-8835
Senior Vice President and CFO
or
Investor Relations Agency:
The Blueshirt Group
Suzanne Craig, 415-217-4962
suzanne@blueshirtgroup.com
Melanie Friedman, 415-217-4964
melanie@blueshirtgroup.com

KEYWORDS:   United States  North America  California  New York

INDUSTRY KEYWORDS:

The article Ultratech, Inc. Announces Participation in March Conferences originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

(function(c,a){window.mixpanel=a;var b,d,h,e;b=c.createElement(“script”);
b.type=”text/javascript”;b.async=!0;b.src=(“https:”===c.location.protocol?”https:”:”http:”)+
‘//cdn.mxpnl.com/libs/mixpanel-2.2.min.js’;d=c.getElementsByTagName(“script”)[0];
d.parentNode.insertBefore(b,d);a._i=[];a.init=function(b,c,f){function d(a,b){
var c=b.split(“.”);2==c.length&&(a=a[c[0]],b=c[1]);a[b]=function(){a.push([b].concat(
Array.prototype.slice.call(arguments,0)))}}var g=a;”undefined”!==typeof f?g=a[f]=[]:
f=”mixpanel”;g.people=g.people||[];h=[‘disable’,’track’,’track_pageview’,’track_links’,
‘track_forms’,’register’,’register_once’,’unregister’,’identify’,’alias’,’name_tag’,
‘set_config’,’people.set’,’people.increment’];for(e=0;e<h.length;e++)d(g,h[e]);
a._i.push([b,c,f])};a.__SV=1.2;})(document,window.mixpanel||[]);
mixpanel.init("9659875b92ba8fa639ba476aedbb73b9");

…read more
Source: FULL ARTICLE at DailyFinance

DexCom Announces Upcoming Conference Presentations

By Business Wirevia The Motley Fool

Filed under:

DexCom Announces Upcoming Conference Presentations

SAN DIEGO–(BUSINESS WIRE)– DexCom, Inc. (NAS: DXCM) today announced that management will present an update on DexCom at the following upcoming investor conferences:

  • Terry Gregg, Chief Executive Office, will present an update on DexCom at the Barclays Global Healthcare Conference in Miami, Florida on Wednesday, March 13, 2013 at 2:30 p.m. (EST). The presentation, which will occur live at the Loews Miami Hotel, will be concurrently webcast.
  • Steve Pacelli, EVP, Strategy and Corporate Development, will present an update on DexCom at the 25th Annual ROTH Conference in Laguna Niguel, California on Monday, March 18, 2013 at 11:30 a.m. (PST). The presentation, which will occur live at the Ritz-Carlton, Laguna Niguel, will be concurrently webcast.

The link to each webcast will be available on the DexCom website at www.dexcom.com by navigating to “About”, then “Investor Relations”, and then “Events and Webcasts”, and the presentations will be archived there for future reference.

About DexCom, Inc.

DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital.

Cautionary Statement Regarding Forward Looking Statements

DexCom is a medical device company with a limited operating history. Successful commercialization of the company’s products is subject to numerous risks and uncertainties, including a lack of acceptance in the marketplace by physicians and patients, the inability to manufacture products in commercial quantities at an acceptable cost, possible delays in the company’s development programs, the inability of patients to receive reimbursement from third-party payors and inadequate financial and other resources. Certain of these risks and uncertainties, in addition to other risks, are more fully described in the company’s annual report on Form 10-K for the fiscal year ended December 31, 2012, as filed with the Securities and Exchange Commission on February 21, 2013.

DexCom, Inc.
Steven R. Pacelli
Executive Vice President, Strategy and Corporate Development
858-200-0200

KEYWORDS: …read more
Source: FULL ARTICLE at DailyFinance

WWE® CFO George Barrios to Participate in the 25th Annual ROTH Conference on March 19th

By Business Wirevia The Motley Fool

Filed under:

WWE ® CFO George Barrios to Participate in the 25th Annual ROTH Conference on March 19th

STAMFORD, Conn.–(BUSINESS WIRE)– WWE (NYS: WWE) announced today that its Chief Financial Officer, George A. Barrios, will participate in the 25th Annual ROTH Conference for investors on March 19th in Laguna Niguel, CA.

Mr. Barrios’ remarks are expected to begin at approximately 4:30 p.m. ET. A live audio webcast will be available online at corporate.wwe.com/investors. Also, a replay of the presentation will begin shortly after the actual presentation time and will be available for one year.

About WWE:

WWE, a publicly traded company (NYS: WWE) , is an integrated media organization and recognized leader in global entertainment. The company consists of a portfolio of businesses that create and deliver original content 52 weeks a year to a global audience. WWE is committed to family friendly entertainment on its television programming, pay-per-view, digital media and publishing platforms. WWE programming is broadcast in more than 145 countries and 30 languages and reaches more than 600 million homes worldwide. The company is headquartered in Stamford, Conn., with offices in New York, Los Angeles, Miami, London, Mumbai, Shanghai, Singapore, Istanbul and Tokyo.

Additional information on WWE (NYS: WWE) can be found at wwe.com and corporate.wwe.com. For information on our global activities, go to http://www.wwe.com/worldwide/.

Trademarks: All WWE programming, talent names, images, likenesses, slogans, wrestling moves, trademarks, logos and copyrights are the exclusive property of WWE and its subsidiaries. All other trademarks, logos and copyrights are the property of their respective owners.

Forward-Looking Statements: This press release contains forward-looking statements pursuant to the safe harbor provisions of the Securities Litigation Reform Act of 1995, which are subject to various risks and uncertainties. These risks and uncertainties include, without limitation, risks relating to maintaining and renewing key agreements, including television and pay-per-view programming distribution agreements; the need for continually developing creative and entertaining programming; the continued importance of key performers and the services of Vincent McMahon; the conditions of the markets in which we compete and acceptance of the Company’s brands, media and merchandise within those markets; our exposure to bad debt risk; uncertainties relating to regulatory and litigation matters; risks resulting from the highly competitive nature of our markets; uncertainties associated with international markets; the importance of protecting our intellectual property and complying with the intellectual property rights of others; risks …read more
Source: FULL ARTICLE at DailyFinance

Actuate to Present at the 25th Annual Roth Conference

By Business Wirevia The Motley Fool

Filed under:

Actuate to Present at the 25 th Annual Roth Conference

SAN MATEO, Calif.–(BUSINESS WIRE)– Actuate Corporation (NAS: BIRT) , The BIRT Company™ – delivering more insights to more people than all BI companies combined, today announced that the Company’s Chief Executive Officer, Pete Cittadini and Chief Financial Officer, Dan Gaudreau will present at the 25th Annual Roth Conference at the Ritz-Carlton in Laguna Niguel.

The presentation will take place on Tuesday, March 19, 2013 at 2:30 p.m. Pacific Time. One-on-one meetings with management can be arranged through Roth. A live webcast of the presentation will be available at www.actuate.com/investor. A replay of the webcast will be available for a limited time thereafter.


Actuate – The BIRT Company™

Actuate founded and co-leads the BIRT open source project, which is used by over 1.5 million developers around the globe and serves as the foundation of the ActuateOne® platform. Applications built on ActuateOne deliver more business and consumer insights to more people than all BI companies combined – ensuring organizations are ready for the exponential growth of Big Data and the proliferation of touch devices.

The ActuateOne platform empowers developers to rapidly develop custom, BIRT-based business analytics and customer communications applications. ActuateOne applications built with one BIRT design, can access and integrate any data, including unstructured sources. They provide one user experience regardless of skill level and are supported by one platform for any cloud, hybrid, on-premise, web or touch device deployment.

Headquartered in Silicon Valley, Actuate has over 5,000 customers globally in a diverse range of business areas including financial services,technology and the public sector. Actuate is listed on NASDAQ under the symbol BIRT. For more information, visit www.actuate.com or engage with the BIRT community at www.birt-exchange.com.

Copyright © 2013 Actuate Corporation. All rights reserved. Actuate, ActuateOne, BIRT Analytics and the Actuate logo are trademarks or registered trademarks of Actuate Corporation and/or its affiliates in the U.S. and certain other countries. The use of the word “partner” or “partnership” does not imply a legal partnership relationship between Actuate and any other company. All other brands, names or trademarks mentioned may be trademarks of their respective owners.

Vertex Energy, Inc. to Present at the 25th Annual Roth Conference on March 19, 2013

By Business Wirevia The Motley Fool

Filed under:

  Vertex Energy, Inc. to Present at the 25th Annual Roth Conference on March 19, 2013

HOUSTON–(BUSINESS WIRE)– Vertex Energy, Inc. (NASDAQ:VTNR), an environmental services company that recycles industrial waste streams and off-specification commercial chemical products, announced that Benjamin Cowart, Chairman and CEO, will present at the 25th Annual ROTH Conference to be held at The Ritz-Carlton, Laguna Niguel, CA on Tuesday, March 19, 2013 at 11:00 a.m. (Pacific Time). The presentation will be webcast live and will be available until March 29, 2013 in the Investor Relations section of the Company’s website at www.vertexenergy.com.

ABOUT VERTEX ENERGY, INC.

Vertex Energy, Inc. (NASDAQ:VTNR), is a leading environmental services company that recycles industrial waste streams and off-specification commercial chemical products. Its primary focus is recycling used motor oil and other petroleum by-product streams. Vertex Energy purchases these streams from an established network of local and regional collectors and generators. The company also manages the transport, storage and delivery of the aggregated feedstock and product streams to end users, and manages the re-refining of a portion of its aggregated petroleum streams in order to sell them as higher-value end products. Vertex Energy sells its aggregated petroleum streams as feedstock to other re-refineries and fuel blenders or as replacement fuel for use in industrial burners. The re-refining of used motor oil that Vertex Energy manages takes place at a facility operated by a related party that uses a proprietary Thermal Chemical Extraction Process (“TCEP”) technology. Based in Houston, Texas, Vertex Energy also has offices in Georgia and California. More information on the company can be found at www.vertexenergy.com.

This press release may contain forward-looking statements, including information about management’s view of Vertex Energy’s future expectations, plans and prospects, within the safe harbor provisions under The Private Securities Litigation Reform Act of 1995 (the “Act”). In particular, when used in the preceding discussion, the words “believes,” “expects,” “intends,” “plans,” “anticipates,” or “may,” and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act, and are subject to the safe harbor created by the Act. Any statements made in this news release other than those of historical fact, about an action, event or development, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors, which may cause the results of Vertex Energy, its divisions and concepts to be materially different than those expressed or implied in such statements. These risk factors and others are included …read more
Source: FULL ARTICLE at DailyFinance

Connecticut's cross-dressing meth priest reportedly liked sex in rectory

The Catholic priest indicted by a federal grand jury in an alleged nationwide methamphetamine ring was reportedly suspended after Connecticut church officials discovered he was a cross-dresser who was having sex in the rectory at Bridgeport’s St. Augustine Cathedral.

The Connecticut Post reports that Monsignor Kevin Wallin was relieved of his duties in May, but the Roman Catholic Diocese of Bridgeport continued to pay the 61-year-old man a stipend until his Jan. 3 arrest. Wallin had planned to fly to London that day, the newspaper reports.

At one point, Wallin, who is now dubbed “Msgr. Meth” by some, was selling upwards of $9,000 of meth a week, including shipments from Connecticut to California, according to his indictment.

In his post-priesthood life, Wallin, of Waterbury, purchased an adult specialty and video store in North Haven called Land of Oz that sold sex toys and adult videos. Investigators believe the shop helped him launder thousands of dollars in weekly profits, the newspaper reports.

Wallin’s arrest shocked residents throughout Bridgeport and Danbury, where he was known as a charismatic speaker who was involved in many charitable activities. He often attended musicals with his mentor, former New York Cardinal Edward Egan and parishioners.

“There is an evil invading our world and it has come to our church,” longtime St. Augstine parishioner Maria Spencer-Fonseca told the newspaper. “This was a work of evil — and I am praying for the monsignor.”

Therese Ruppert, a parishioner at the Church of St. Peter in Danbury, where Wallin was pastor from 1996 to 2002, said she “can’t fathom” the news.

“He was so spiritual,” Ruppert told the newspaper. “His sermons were wonderful. He had such knowledge of theology.”

Wallin, who is represented by a federal public defender, was among five people indicted Tuesday on charges of conspiring to distribute 500 grams or more of a substance containing methamphetamine and 50 grams of actual methamphetamine. Wallin has been jailed without bond pending an arraignment next week and faces at least 10 years to life in prison if convicted.

Also charged are Kenneth Devries, 52, of Waterbury; Michael Nelson, 40, of Manchester; Chad McCluskey, 43, of San Clemente, Calif.; and Kristen Laschober, 47, of Laguna Niguel, Calif.

Wallin resigned as St. Augustine’s pastor in June 2011 after serving nine years in the post, citing health and personal issues, the Diocese of Bridgeport said in a statement. Diocese officials granted him a sabbatical the following month.

During the sabbatical, diocese officials became concerned about Wallin’s well-being and reached out to him, but he has never spoken directly to church officials, the diocese said in the statement, which did not elaborate.

Wallin’s faculties for public ministry were suspended in May 2012 and he has not been reassigned, the diocese said.

“News of Msgr. Kevin Wallin‘s arrest comes with a sense of shock and concern on the part of the diocese and the many people of Fairfield County who have known him as a gifted, accomplished and compassionate priest,” the diocese said. “The diocese stands ready to help as it has throughout the past two years. We ask for prayers for Msgr. Wallin during the difficult days ahead for him.”

The Associated Press contributed to this report.

Click for more from CTPost.com.

Source: FULL ARTICLE at Fox US News